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Background: Identification of viable slow conduction zones manifested by abnormal local potentials is integral to
catheter ablation of ventricular tachycardia (VT) sites. The relationship between contrast patterns in cardiovascular
magnetic resonance (CMR) and local electrical mapping is not well characterized. The purpose of this study was to
identify regions of isolated, late and fractionated diastolic potentials in sinus rhythm and controlled-paced rhythm
in post-infarct animals relative to regions detected by late gadolinium enhancement CMR (LGE-CMR).
Methods: Using a real-time MR-guided electrophysiology system, electrogram (EGM) recordings were used to
generate endocardial electroanatomical maps in 6 animals. LGE-CMR was also performed and tissue classification
(dense infarct, gray zone and healthy myocardium) was then correlated to locations of abnormal potentials.
Results: For abnormal potentials in sinus rhythm, relative occurrence was equivalent 24%, 27% and 22% in dense
scar, gray zone and healthy tissue respectively (p = NS); in paced rhythm, the relative occurrence of abnormal
potentials was found to be different with 30%, 42% and 21% in dense scar, gray zone and healthy myocardium
respectively (p = 0.001). For location of potentials, in the paced case, the relative frequency of abnormal EGMs was
19.9%, 65.4% and 14.7% in the entry, central pathway and exit respectively (p = 0.05), putative regions being
defined by activation times.
Conclusions: Our data suggests that gray zone quantified by LGE-CMR exhibits abnormal potentials more frequently
than in healthy tissue or dense infarct when right ventricular apex pacing is used.
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Ventricular tachycardia (VT) associated with chronic
myocardial infarction are the leading cause of sudden
cardiac death [1]. To guide ablation therapy, conven-
tional electrophysiology (EP) substrate mapping delin-
eates the myocardial infarct area using voltage mapping,
then uses pace-mapping to define the VT exit as well as
local electrogram (EGM) characteristics to identify areas
with slow conduction [2]. In the majority of VT cases aris-
ing after the patient has suffered a myocardial infarction,
slow conduction regions are part of the re-entry circuit in
the arrhythmogenic substrate [1], often detected with the* Correspondence: soduneye@sri.utoronto.ca
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unless otherwise stated.voltage maps as well. These regions of the re-entrant path
have been found to contain diastolic potentials [3]. These
abnormal local electrograms (EGMs) originate from the
propagation across surviving viable myocardium separated
by fibrosis in a zig-zag activation pattern [4,5]. The com-
bined local conduction delays produce abnormal signals
with multiple signal components, each representing the
nonsynchronous depolarization of the different bundles
of the surviving myocardial fibers. These abnormal poten-
tials, recorded during electroanatomical mapping, are
classified as fractionated potentials or as isolated/late po-
tentials. Diastolic and fractionated potentials are pathog-
nomonic potentials for VT substrate and their locations
are the effective targets for ablative therapy [6].al. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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studies. Hsia et al. [1,7] compared the correlation be-
tween late potentials and arrhythmogenic substrate of
reentrant VT circuits and found that, out of the 133 sites
recorded, a higher prevalence of late potentials were re-
corded near the isthmus (89%) compared to entrance
(57%) or exit (20%). Similarly, comparable studies have
identified higher prevalence of late potentials at sites
classified as central or proximal in the reentry circuit as
compared to other sites (exit or outer loop sites) [8,9].
Abnormal potentials were shown not only to correlate
with the reentry pathway but also to have direct corres-
pondence to successful ablation targets. When ablation
strategies have focused on targeting isolated potentials
the results have proven to be effective [4,5,10]. Further-
more, other studies have also indicated that abnormal
potentials can be used to identify critical isthmuses with
signals recorded during sinus rhythm (SR) [6,11,12],
paced-controlled rhythm [6] or both [10,13].
Therefore, we aimed to: 1) identify regions of isolated/
late and fractionated potentials in sinus rhythm and
controlled-paced rhythm in post-infarct animals; and 2)
to characterize the relative prevalence of these abnormal
potentials in critical sites and areas labeled as gray zone
as quantified by late gadolinium enhancement cardiovas-
cular magnetic resonance (LGE–CMR).
Methods
Animal preparation
Six pigs weighing an average of 35 kg were used for the
study. The chronic infarct model was obtained for each
animal by undergoing infarct induction and four weeks
recovery; after approximately the four weeks, an MR-
guided EP procedure was conducted. Before each pro-
cedure, animals were placed under general anesthesia in-
duced with an intramuscular injection of ketamine
(30 mg/kg) and atropine (0.05 mg/kg), and maintained
by inhalation of 1-5% isoflurane. Also lidocaine (30 ml
of 2% lidocaine in 250 ml of saline) and 50 mg/ml amioda-
rone, were administered during the procedure; anticoagu-
lation with intravenous heparin (70 units/kg) was also
administered. Then, the animals were intubated and
mechanically ventilated (20–25 breaths/minute). For in-
farct induction, complete coronary occlusion was achieved
distal to the second diagonal branch of the left anterior
descending artery (LAD) for 90 minutes or 60 minutes by
inflation of a percutaneous balloon dilation catheter
(Sprinter Legend Balloon Catheter, Medtronic, Minneap-
olis, MN), and was followed by reperfusion. The different
occlusion times change the extent and heterogeneity of
the infarct.
For the EP procedure, incisions of femoral vessels, ca-
rotid artery and/or jugular vein were performed and ac-
cess secured with 9 F introducer sheaths for the purposeof administering medications and inserting mapping
catheters. Finally, ECG leads I, II, and III were moni-
tored throughout the infarct induction procedure as well
as the electrophysiology procedure to track animal
health. The animal care committee at Sunnybrook Re-
search Institute approved this protocol and all the proce-
dures were conducted following institutional guidelines.
Imaging protocol and image processing
A 1.5 T GE Signa (GE Healthcare, Milwaukee, USA)
with a 5-inch surface coil was used to acquire anatom-
ical scans. The left and right ventricle were fully imaged
in long axis and short axis directions, yielding multiple
2D MR images using a respiratory gated sequence.
The principal anatomical scans were performed with
SSFP-CINE with the following parameters: TE/TR = 1.1/
3.6 ms, FA = 45°, BW = 62.5 kHz, NEX = 1, and views
per segment (vps) = 12, slice thickness = 5 mm, FOV =
210 mm (phase FOV 0.8 or 0.9), Nx = 224, Ny = 160.
This resulted in an approximate in-plane resolution of
0.9 × 1.2 mm. The cine SSFP sequence produced 20
phases over the heart cycle, acquired on average over
10–15 second breath-holds. Following the anatomical
scans, we performed LGE imaging using a multi contrast
late enhancement (MCLE) sequence recently developed
in our lab [14]. MCLE was shown to yield more reliable
and reproducible measures of the infarct core and gray
zones than conventional techniques. This sequence pro-
duces images with multiple contrasts where infarct can
be visualized as an area of fast T1* recovery (T1* is the
apparent T1 relaxation, shorter than the true T1 due to
the continuous SSFP readout). The MR scans started
5 minutes after injection of 0.44 mmol/kg of Gd-DTPA
(Magnevist, Berlex Inc., Wayne, NJ). The parameters for
the MCLE sequence were: TR/TE = 2.7/1.3 ms, readout
FA = 45°, BW = ±125 kHz, VPS = 16, FOV = 210 mm,
slice thickness = 5 mm, 192 × 160 (phase FOV 0.8 or 0.9)
imaging matrix and NEX = 1. An inversion pulse was
placed such that the infarct-enhanced images from the
continuous SSFP acquisition are acquired during diastole.
The resulting images from the MCLE sequence were used
to classify the different myocardial tissues states. Six
to eight images were utilized from the diastolic cardiac
phase to extract the signal recovery rate (1/T1*) and the
steady-state plateau of the recovery curve signal for each
pixel within the (left ventricle) LV. After obtaining T1*
and steady-state values for each pixel, we used a fuzzy
C-means algorithm to automatically classify each pixel as
infarct, healthy myocardium, gray zone, or blood, as previ-
ously described in [14]. We segmented the infarct core,
gray zone and healthy myocardium in each of our MCLE
short-axis images (see Figure 1a). The classification results
were processed and imported into our electrophysiology
visualization system as an endocardial mesh (Figure 1c).
Figure 1 Fusion of multi-contrast late enhancement information and voltage signal of electroanatomical map. (a) LGE images using the
MCLE sequence (or steady-state T1*) were processed using a fuzzy clustering algorithm to classify each pixel as infarct (green), healthy myocardium (purple),
or gray zone (yellow). (b) SSFP-derived meshes were overlaid with voltage amplitude information obtained from the MR-Guided endocardial mapping
procedure, resulting in an EAVM (color coded as per color bar). (c) After the procedure, EP meshes were fused with the MCLE-derived images.
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The MR-guided EP apparatus was comprised of 8.5Fr
MR-compatible Vision™ catheters, (Imricor Medical Sys-
tems, Burnsville, USA) and a prototype Bridge™ EP Re-
cording System (Imricor Medical Systems, Burnsville,
MN); we used a 4-electrode catheter with 2 mm spacing
between the first two distal electrodes, 3 mm spacing
between second and third electrode and 1 mm spacing
between third and fourth electrode. Bipolar recordings
were made with the distal electrode pair (1 and 2). The
catheters were placed in the (right ventricle) RV or LV
using active catheter tracking with MR-guidance as re-
ported previously [15]. The catheters were advanced
under full MR guidance with a 3D LV shell created from
segmentation of SSFP-cine images acquired in the same
session, with the animal resting in the same position; this
eliminated the need for additional registration or align-
ment. The LGE images were loaded into the visualization
software Vurtigo (vurtigo.ca) to directly identify the navi-
gation targets, (i.e., the infarcted areas) (see Figure 1). At
each point of contact, the intracardiac signals and the
three-dimensional spatial coordinates were recorded. As
detailed in our previous study we calculated spatial error
associated with fusion of EAM surface and EP points by
measuring the average perpendicular distance between EP
points and mesh surface [15].
Electrophysiology procedure
Using the MR-guided EP system, we conducted substrate
mapping during sinus rhythm for each animal, right
after the imaging acquisition. The EP mapping data was
collected in the following sequence: 1) a voltage map
was constructed for the endocardial surface of the left
ventricle under real-time MR guidance;
2) Right ventricular apex (RVA) electrical stimulation
was then performed, with a second catheter advanced
into the right ventricle to reduce overlap of action po-
tential signals commonly seen in the porcine model. Forthe latter, performing pacing at a rate faster than the ani-
mal’s normal sinus rhythm (on average 400 msec cyc-
ling) and increasing the current until muscle capture
was assured, the natural pacemaker was overridden. Ab-
normal potentials were defined in the following manner:
1) distinct bipolar electrogram recordings inscribed after
the end of the RVA reference signal (R-peak), separated
from the major initial component of the local ventricular
electrogram with an isoelectric interval greater than
20 ms [11] in both sinus and paced cases; and 2) frac-
tionated potentials as multicomponent signals of long
duration >133 ms [8] and greater than underlying signal
noise (0.1 mV) in both sinus and paced rhythms. The
former method is an internationally accepted method
from Bogun et al. [11], while the later, as described in
the above-reference, is more recent. The remaining
EGMs displaying both above-mentioned characteristics
were also defined as abnormal. Only endocardial sites
with bipolar electrogram recordings acquired during
sinus or right ventricular pacing were analyzed for
abnormal EGMs (see Figure 2). All EGMs recordings
within the LV EP map were analyzed for the presence or
absence of abnormal potentials. EGMs with high elec-
trical noise, or poor signal quality reducing accurate
assessment of abnormal EGMs were discarded. Signal
definition and rejection at this time it was conducted
visually and manually, with an experienced observer.
To estimate the degree of local activation time delay in
the LV, an isoelectric interval was measured as the tim-
ing interval from the onset of the second upstroke in the
ventricular electrogram (verified by the corresponding
RVA reference signal) to the earliest component of the
abnormal EGM. The incidence of abnormal EGMs in
different infarct regions as defined by voltage amplitudes
and by LGE-CMR was determined. Regions of low volt-
age potentials were classified as those with voltage amp-
litude < 1.5 mV, specifically < 0.5 mV for dense scar and
0.5 mV-1.5 mV for gray zone [2]. Critical central
Figure 2 Examples of abnormal EGMs recordings from animals with myocardial infarction. Shown are the EGM recordings in RV and LV in
the sinus (a, c, e, g) and paced (b, d, f, h) condition. Tracings (a) and (b) show RVA signals, c and d represent normal healthy myocardium recordings.
The following recordings are all acquired in non-healthy tissue. In (e) and (f) the local EGM recorded by the mapping catheter displays an isolated
potential (oblique arrows) that is separated from the ventricular EGM by an isoelectric line of at least 20 ms. Finally, (g) and (h) are the recorded
EGM fractionated and the width is > 102 ms; (RVA = Right ventricular apex, LV = left ventricle).
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tivation time in infarct or gray zone tissue and it was hy-
pothesized to support VT, in a similar manner as the
isthmus of the reentry circuit.
Statistical analysis
Categorical variables were compared using a chi-squared
test. The test allowed to detect group differences using
frequency (count) data. To determine the statistical sig-
nificance of the frequency of potentials in for different
tissue classifications, the recorded (or observed) poten-
tials and expected abnormal potentials were analyzed;
where the expected potentials corresponded to the nor-
malized distribution.To determine the statistical signifi-
cance of the frequency of potentials in the different
presumed locations/regions of the slow conduction path
(entry, exit and critical central pathway), we compared
observed and expected proportion with a chi-square test(http://graphpad.com/quickcalcs/chisquared1/ and http://
www.quantpsy.org/chisq/chisq.htm). Continuous variables
were compared using one-way ANOVA test (http://
danielsoper.com/statcalc3/). A value of p < 0.05 was con-
sidered statistically significant. MATLAB (The Math-
works, Natick, MA) was used for statistical analyses.
Results
Electrophysiology mapping
In our studies during the electrophysiology mapping, we
recorded a total of 3945 good quality EGMs from 6 ani-
mals. EGMs were recorded in both SR (2469 points) and
paced rhythm (1476 points). During SR the signals re-
corded resulted in 609 low voltage EGMs and 558 ab-
normal EGMs; for the paced rhythm, 308 and 360
EGMs were founds to be low voltage and abnormal re-
spectively. Also, our analysis focused on the relationship
between abnormal potentials and tissue properties as
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processed and imported into Vurtigo as an endocardial
mesh. Abnormal potentials recorded during the mapping
procedure were assigned to locations on the tissue clas-
sification mesh using a closest point algorithm; this
process resulted in EGM characteristic to tissue property
pairings for various regions.
Out of the 2469 points in SR and 1476 in paced rhythm
points, we recorded 758, 147 and 1544 EGMs from MR-
defined regions of dense infarct, gray zone and healthy
myocardium respectively in the SR case. For the paced
case we recorded 378, 55 and 1043 EGMs for MR-defined
dense infarct, gray zone and healthy myocardium respect-
ively. Results are summarized in Figure 3. Finally, the aver-
age spatial error due to cardiac and respiratory motion of
the acquired mapping points was calculated to be 2.1 ±
1.1 mm.
Distribution of abnormal potential signals in different
cardiac rhythms
Sites classified as dense scar, gray zone, and healthy
myocardium by MRI within the low voltage and abnor-
mal potentials groups were further examined. Relative
prevalence of abnormal EGMs in a given region was cal-
culated as the ratio of EGMs classified as low voltage or
abnormal over the total number of EGMs recorded in
scar, gray zone and healthy myocardium, respectively. In
general, our analysis determined that low-voltage poten-
tials had a higher relative prevalence in dense scar in
sinus, whereas abnormal potentials had a higher relative
percentage in gray zone regions in paced rhythm. Specif-
ically, for low-voltage in sinus rhythm, relative preva-
lence was 28%, 26% and 22% in dense scar, gray zone
and healthy myocardium respectively (p = 0.01 among
the three groups). For low-voltage during pacing the
relative prevalence of low-voltage potentials was 26%,
4% and 20% for dense scar, gray zone and healthyFigure 3 Distribution of abnormal potential recordings in sinus and p
(left); and within scar, gray zone and healthy myocardium regions (rig
GZ = gray zone, HM = healthy myocardium.myocardium respectively (p < 0.001). Conversely, for ab-
normal potentials in sinus rhythm, relative prevalence
was equivalent for all EGM measurements in the
mapped regions of interest, and calculated to be 24%,
27% and 22% (p = 0.3) in dense scar, gray zone and
healthy tissue respectively; in the paced rhythm case the
relative prevalence of abnormal EGMs was 30%, 42%
and 21% (p = 0.001 between each group) in dense scar,
gray zone and healthy myocardium respectively. These
results are summarized in Table 1. Finally, our results in-
dicate that in paced rhythm gray zone has higher fre-
quency of abnormal potentials with respect to healthy
myocardium (p < 0.01) and statistically trending towards
higher frequency with respect to dense scar (p < 0.1).
Distribution of abnormal potential signals in different
locations
Distributions of abnormal potentials across locations in
assumed target regions as a function of rhythm were
also analyzed. The target regions of the presumed slow
conduction path (entry, critical central pathway and exit,
see Figure 4) were inferred from depolarization times of
local activation/arrival signals relative to all activation
times. Local activation times for recorded points classi-
fied as dense infarct and gray zone were subdivided into
quartiles for each animal (note, health myocardium was
not included): 1) the first quartile of the earliest activa-
tion times within MR-determined regions of dense in-
farct or gray zone were classified as being associated
with the entry; 2) 2nd and 3rd quartile were classified as
within the critical central pathway; and 3) latest activa-
tion times (4th quartile) are considered to be within
the exit region. The choice of quartile regions was made
to favour repeatability of calculations and analysis. Only
relative activation times in the dense infarct and gray
zone were considered, to reduce any bias due to the
presence of health myocardium or excessive distanceaced rhythm for low voltage potentials and abnormal potentials
ht) of the endocardium. Low Volt = low voltage, DS = dense scar,
Table 1 Distribution of abnormal potential EGMS recorded in scar, gray zone and healthy regions
Animals N = 6 Sinus rhythm Paced rhythm
Dense scar Gray zone Healthy myo p-value Dense scar Gray zone Healthy myo p-value
Total EGMs recorded 758 147 1544 378 55 1043
Low voltage potentials 214 (28%) 38 (26%) 337 (22%) p = 0.01 98 (26%) 2(4%) 208 (20%) p = 0.01
Abnormal potentials 183 (24%) 39 (27%) 336 (22%) p = 0.3 113 (30%) 23(42%) 224 (21%) p = 0.001
Values in parentheses indicate fraction of low voltage or abnormal potentials as a percentage of total EGMs in scar, gray zone or myocardium. EGMs are shown in
rhythm and vs. paced rhythm. p-values are calculated as the difference between the tissue groups.
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tion of all measured potentials across entry, critical
central pathway and exit will be, by definition, 25%-50%-
25% respectively. Considering only the abnormal poten-
tials observed in these regions we asked if their spatial
distribution was different than that for all potentials.
Our results show a signficant and relative difference be-
tween the sinus rhythm case and paced case. Specifically,
our results show that, in the sinus case, there is an unex-
pectedly high relative fraction at the exit, specifically
21.2%, 42.8%, and 36.0% of the abnormal potentials in
the regions were seen in the entry, central pathway, and
exit regions respectively; in the paced case, the abnormal
EGMs were more likely to be seen in the central pathway
region, with distribution of 19.9%, 65.4% and 14.7% in the
entry, critical central pathway and exit regions respectively
(as shown in Figure 5). Using a comparison of proportion
test, we determined that each of these distributions dif-
fered from the expected distribution of 25:50:25 in a sta-
tistically significant way (p < 0.05). The significance of
these findings is presented in the next section.
Discussions
Abnormal potential signals distribution
The main findings of this study are that: (1) abnormal
potentials are more prevalent in the MR-defined gray
zone and (2) this relationship is more evident duringFigure 4 Activation map recorded during mapping procedure. The co
activated areas typical of later activation time capable of supporting VT. Th
pathway. a) classification of tissue b) map of time of depolarization. Arrow
presumed slow conduction path.RVA pacing. CMR determined gray zone has been
shown to correlate with all-cause post-MI mortality and
with inducibility for VT for patients with myocardial in-
farct scars; therefore it would be important to
characterize the prevalence of abnormal potentials in
areas labeled as gray zone as quantified by LGE–CMR.
Our data suggest that abnormal potentials are more
prevalent in the MR-defined gray zone, particularly dur-
ing pacing. This is a novel finding, and provides add-
itional insights into the analysis of RVA stimulation; It
is believed that overlapping activation fronts may limit
the identification of multiple components during sinus
rhythm, where overlapping refers to the activation of
various parts of the myocardium due to non-uniform ac-
tivation of the endocardium generated by the Purkinje
fibers as well as to beat-to-beat heart rhythm variability
in sinus rhythm. This limitation can be mitigated by
simplifying the evaluation to one propagation front; spe-
cifically, RVA pacing from a known location creates a
dominant action potential wavefront that can identify
abnormal potentials otherwise not detected [6]. Our re-
sults are consistent with this notion as RVA pacing sup-
presses overlapping signals and reduces the influence of
adrenergic and cholinergic nerve fibers present on the
swine endocardium. The heterogeneous nature of gray
zone with bundles of surviving myocytes responsible for
the irregular propagation of the action potential maylor index reveals the continuity between the earliest and latest
e presumed depolarization wavefront is drawn to indicate potential
shows presumed slow conduction path; c) designation of regions in
Figure 5 Distributions of abnormal potentials. Entry, critical central pathway and exit are shown in the figure. The distribution of abnormal
potentials is based on Figure 2. The critical central pathway location is associated with the presence of abnormal potentials. Using a comparison
of proportion test, we determined that the frequencies between each distribution were statistically significant p < 0.05.
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with previous studies that hypothesized that overlapping
of EGMs or a particular orientation of a line of block
with respect to the activation front may preclude the
identification of multiple components during SR [6].
This limitation can be overcome by changing the activa-
tion front, such as during RVA pacing, to identify other-
wise undetected abnormal EGMs. This is important
because the authors of the previous study also claim that
these EGMs could better identify VT-related slow con-
duction areas relative to low-amplitude electrograms [6].
Further, we noticed that in both sinus and paced rhythm
there was a percentage of low volume abnormal poten-
tials in healthy tissue. Based on visual inspection we no-
ticed that such points were recorded recorded in healthy
myocardium, which was located adjacent to the infarct
region. In addition, a few points of low voltage in healthy
myocardium were also acquired very close or touching
the valve, while others probably did not have a very good
contact with the ventricular.
Our results showes a lower prevalence of low voltage
points in gray zone than health myocardium in the
paced rhythm case; Although gray zone in that case
showed a lower prevalence of low voltage points, the
average signal amplitude was lower than in the healthy
myocardium. So while the average signal in the healthy
myocardium was above 1.5 mV, there were several low
voltage points. We also found that, in the paced case, ahigher relative percentage of abnormal signal potentials
was associated with sites in the presumed slow central
pathway compared to entry or exit, based on activation
activation times. These findings are in line with findings
of Nakahara et al. [13], where a higher concentration of
abnormal EGMs (late potentials) was found in the puta-
tive isthmus and also with Hsia et al. [7], where the
majority of these delayed and fractionated endocardial
electrogram recordings were found in critical central
pathway sites. In this study we did not report nor con-
duct a rigorous correlation study between low-voltage
and MR-defined dense scar, since it was the focus of our
previous publication [15].
Abnormal potentials are more associated with the lo-
cation of the VT isthmus than low amplitude potentials
[6,7,11,16]. Locations of VT-related conducting channels
have been shown to be only grossly estimated by low
peak bipolar voltages (<1.5 mV) measured during SR
without tachycardia induction. Also, recently it has been
shown that the presence of isolated potentials inside
the voltage channel significantly increases the specificity
for identifying the clinical VT isthmus [17]. Further-
more, linear radiofrequency ablation lesions designed to
transect these channels of slow conduction have been
shown to be on average longer in length by several
centimeters when the isthmus has not been effectively
identified and only voltage maps are known (e.g. in
hemodynamically unstable patients) [18]. In contrast,
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times can identify VT-related slow conduction regions.
Specifically, sites with isolated/late potentials and frac-
tionated potentials during sinus/paced rhythm reflect
late local activation of bundles of healthy myocytes that
enable conduction and become critical components of a
reentry circuit. Abnormal potentials acquired during
endocardial mapping have been shown to correspond to
appropriate ablation targets with greater specificity than
simple peak voltage mapping [10,19].
Identifying abnormal potentials becomes especially im-
portant in cases where the patient has hemodynamically
unstable VT, or non-inducible VT; otherwise, in these
patients, electrophysiologists only have the information
from the voltage maps, which as noted above, have low
specificity for VT substrate identification [2,6]. Point-
by-point mapping of the LV is time consuming and leads
to prolonged procedure/anesthesia time, and the low
specificity of this technique requires additional diagnos-
tic procedures [6]. The point-by-point mapping also has
limitations related to catheter-tissue contact and largely
unspecified spatial resolution. In our previous study [15]
we showed that CMR information used in electrophysi-
ology studies can accurately predict areas of myocardial
fibrosis identified with bipolar voltage mapping. We
believe that a strategy for identification of sites for map-
ping and ablation is achievable when using CMR com-
bined with abnormal electrical signal information; this
added information is desirable to due to its greater specifi-
city compared to peak voltage mapping alone. More spe-
cifically, gray zone volume with LGE-CMR has been
shown to correlate with all-cause post-MI mortality and
with inducibility for ventricular tachycardia (VT) [20,21].Conclusions
Our data suggests that gray zone quantified by LGE-
CMR has high correspondence to regions with a high
proportion of abnormal potentials. This correspondence
is higher when right ventricular apex stimulation is
employed. Abnormal electrograms are commonly ob-
served in sinus rhythm and paced rhythm from and in
close proximity to slow central pathways in other stud-
ies. Future investigation into the clinical outcome associ-
ated with ablation of VT using gray zone information
and signal morphology is warrantedAbbreviations
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